Cassandra Erato, MSN
Chief Executive Officer
Spaulding Clinical, LLC
Talk to Cassie about these topics and more:
- Navigating U.S. regulatory requirements, IND Submission, and Phase 1 startup and conduct
- Efficiencies and guidance in running Phase 1 of clinical development
- Understanding cardiac safety requirements and the best cost-saving methods
- Developing new service programs as needs emerge
- Rapid operational scaling/growth, strategic planning, and recapitalization
Biostatistics
Cardiovascular
CEO
Clinical Data
Clinical Trials
Contract Research Organization (CRO)
Medical Writing
Paperless
Pharmacology
Phase I/Early Phase Research
Preclinical
Regulatory
Strategic Planning
